Literature DB >> 27923018

Understanding immune responses to the influenza vaccine.

Richard Webby1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27923018     DOI： 10.1038/nm.4248

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  7 in total

1.  Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.

Authors:  Susanne L Linderman; Benjamin S Chambers; Seth J Zost; Kaela Parkhouse; Yang Li; Christin Herrmann; Ali H Ellebedy; Donald M Carter; Sarah F Andrews; Nai-Ying Zheng; Min Huang; Yunping Huang; Donna Strauss; Beth H Shaz; Richard L Hodinka; Gustavo Reyes-Terán; Ted M Ross; Patrick C Wilson; Rafi Ahmed; Jesse D Bloom; Scott E Hensley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

2.  Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2016-10-14

3.  Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees.

Authors:  Mark G Thompson; Manjusha J Gaglani; Allison L Naleway; Samuel H Dowell; Sarah Spencer; Sarah Ball; Min Levine; Alicia Fry
Journal:  Vaccine       Date:  2016-05-16       Impact factor: 3.641

4.  Host cell-mediated variation in H3N2 influenza viruses.

Authors:  J M Katz; C W Naeve; R G Webster
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

Review 5.  Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.

Authors:  Florian Krammer; Peter Palese; John Steel
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

6.  Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

Authors:  Ali H Ellebedy; Florian Krammer; Gui-Mei Li; Matthew S Miller; Christopher Chiu; Jens Wrammert; Cathy Y Chang; Carl W Davis; Megan McCausland; Rivka Elbein; Srilatha Edupuganti; Paul Spearman; Sarah F Andrews; Patrick C Wilson; Adolfo García-Sastre; Mark J Mulligan; Aneesh K Mehta; Peter Palese; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

7.  Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Authors:  Danuta M Skowronski; Naveed Z Janjua; Gaston De Serres; Suzana Sabaiduc; Alireza Eshaghi; James A Dickinson; Kevin Fonseca; Anne-Luise Winter; Jonathan B Gubbay; Mel Krajden; Martin Petric; Hugues Charest; Nathalie Bastien; Trijntje L Kwindt; Salaheddin M Mahmud; Paul Van Caeseele; Yan Li
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240
  7 in total
  2 in total

1.  Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.

Authors:  Brendan Flannery; Catherine Smith; Rebecca J Garten; Min Z Levine; Jessie R Chung; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kempapura Murthy; Richard Zimmerman; Mary Patricia Nowalk; Marie R Griffin; H Keipp Talbot; John J Treanor; David E Wentworth; Alicia M Fry
Journal:  J Infect Dis       Date:  2018-06-20       Impact factor: 5.226

Review 2.  The Vestigial Esterase Domain of Haemagglutinin of H5N1 Avian Influenza A Virus: Antigenicity and Contribution to Viral Pathogenesis.

Authors:  Zhiqiang Zheng; Subha Sankar Paul; Xiaobing Mo; Yu-Ren Adam Yuan; Yee-Joo Tan
Journal:  Vaccines (Basel)       Date:  2018-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.